{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:41:03Z","timestamp":1787010063337,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/jcp.0b013e3182549c2a","type":"journal-article","created":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T04:26:50Z","timestamp":1335328010000},"page":"424-425","source":"Crossref","is-referenced-by-count":39,"title":["Finasteride Attenuates Pathological Gambling in Patients With Parkinson Disease"],"prefix":"10.1097","volume":"32","author":[{"given":"Marco","family":"Bortolato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Cannas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Solla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Puligheddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Marrosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-24-20210128","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":". Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch Neurol"},{"key":"R2-24-20210128","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","article-title":". Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.","volume":"67","author":"Voon","year":"2006","journal-title":"Neurology"},{"key":"R3-24-20210128","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1038\/npp.2008.39","article-title":". Antipsychotic-like properties of 5-alpha-reductase inhibitors.","volume":"33","author":"Bortolato","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"R5-24-20210128","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1176\/appi.ajp.2007.07060978","article-title":"Treatment of Tourettes syndrome with FIN.","volume":"164","author":"Bortolato","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R6-24-20210128","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10899-005-5557-3","article-title":". Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS).","volume":"21","author":"Pallanti","year":"2005","journal-title":"J Gambl Stud"},{"key":"R7-24-20210128","first-page":"439","article-title":". Testosterone levels and discounting delayed monetary gains and losses in male humans.","volume":"27","author":"Takahashi","year":"2006","journal-title":"Neuro Endocrinol Lett"},{"key":"R8-24-20210128","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1523\/JNEUROSCI.23-09-03572.2003","article-title":". Sigma 1 receptor-related neuroactive steroids modulate cocaine-induced reward.","volume":"23","author":"Romieu","year":"2003","journal-title":"J Neurosci"},{"key":"R9-24-20210128","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ana.22029","article-title":". Pathological gambling in Parkinson disease is reduced by amantadine.","volume":"68","author":"Thomas","year":"2010","journal-title":"Ann Neurol"},{"key":"R10-24-20210128","first-page":"213","article-title":"Is pathological gambling in Parkinsons disease reduced by amantadine Ann Neurol.","volume":"69","author":"Lee","year":"2011","journal-title":""},{"key":"R11-24-20210128","first-page":"344","article-title":"Mental side effects of amantadine therapy: its spectrum and characteristics in a normal population.","volume":"42","author":"Flaherty","year":"1981","journal-title":"J Clin Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e3182549c2a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T21:59:57Z","timestamp":1620943197000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201206000-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3182549c2a","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}